208 related articles for article (PubMed ID: 8657123)
61. The value of immunohistochemical determination of topoisomerase IIα and Ki67 as markers of cell proliferation and malignant transformation in colonic mucosa.
Stromar IK; Jakic-Razumovic J
Appl Immunohistochem Mol Morphol; 2014 Aug; 22(7):524-9. PubMed ID: 24185119
[TBL] [Abstract][Full Text] [Related]
62. Expression of topoisomerase IIalpha in the G0/G1 cell cycle phase of fresh leukemic cells.
Uggla B; Möllgård L; Ståhl E; Mossberg LL; Karlsson MG; Paul C; Tidefelt U
Leuk Res; 2001 Nov; 25(11):961-6. PubMed ID: 11597731
[TBL] [Abstract][Full Text] [Related]
63. Expression of cyclins A, E and topoisomerase II alpha correlates with centrosome amplification and genomic instability and influences the reliability of cytometric S-phase determination.
Kronenwett U; Castro J; Roblick UJ; Fujioka K; Ostring C; Faridmoghaddam F; Laytragoon-Lewin N; Tribukait B; Auer G
BMC Cell Biol; 2003 Jul; 4():8. PubMed ID: 12875657
[TBL] [Abstract][Full Text] [Related]
64. Immunohistochemical staining of DNA topoisomerase IIalpha in human gliomas.
Taniguchi K; Wakabayashi T; Yoshida T; Mizuno M; Yoshikawa K; Kikuchi A; Nakashima N; Yoshida J
J Neurosurg; 1999 Sep; 91(3):477-82. PubMed ID: 10470824
[TBL] [Abstract][Full Text] [Related]
65. Inhibition of DNA topoisomerase II alpha gene expression by the p53 tumor suppressor.
Wang Q; Zambetti GP; Suttle DP
Mol Cell Biol; 1997 Jan; 17(1):389-97. PubMed ID: 8972219
[TBL] [Abstract][Full Text] [Related]
66. DNA topoisomerase IIalpha protein and mRNA expression in intracranial meningiomas.
Kunishio K; Morisaki K; Matsumoto Y; Nagao S
Brain Tumor Pathol; 2000; 17(3):105-10. PubMed ID: 11310917
[TBL] [Abstract][Full Text] [Related]
67. Effects of wild-type p53 expression on the quantity and activity of topoisomerase IIalpha and beta in various human cancer cell lines.
Hochhauser D; Valkov NI; Gump JL; Wei I; O'Hare C; Hartley J; Fan J; Bertino JR; Banerjee D; Sullivan DM
J Cell Biochem; 1999 Nov; 75(2):245-57. PubMed ID: 10502297
[TBL] [Abstract][Full Text] [Related]
68. Characterization of DNA topoisomerase II alpha/beta heterodimers in HeLa cells.
Gromova I; Biersack H; Jensen S; Nielsen OF; Westergaard O; Andersen AH
Biochemistry; 1998 Nov; 37(47):16645-52. PubMed ID: 9843432
[TBL] [Abstract][Full Text] [Related]
69. Developmental and hormonal regulation of type II DNA topoisomerase in rat testis.
Bakshi RP; Galande S; Bali P; Dighe R; Muniyappa K
J Mol Endocrinol; 2001 Jun; 26(3):193-206. PubMed ID: 11357056
[TBL] [Abstract][Full Text] [Related]
70. DNA cleavage and religation by human topoisomerase II alpha at high temperature.
Bromberg KD; Osheroff N
Biochemistry; 2001 Jul; 40(28):8410-8. PubMed ID: 11444988
[TBL] [Abstract][Full Text] [Related]
71. Altered drug interaction and regulation of topoisomerase IIbeta: potential mechanisms governing sensitivity of HL-60 cells to amsacrine and etoposide.
Grabowski DR; Holmes KA; Aoyama M; Ye Y; Rybicki LA; Bukowski RM; Ganapathi MK; Hickson ID; Ganapathi R
Mol Pharmacol; 1999 Dec; 56(6):1340-5. PubMed ID: 10570063
[TBL] [Abstract][Full Text] [Related]
72. Etoposide-induced cell cycle delay and arrest-dependent modulation of DNA topoisomerase II in small-cell lung cancer cells.
Smith PJ; Souès S; Gottlieb T; Falk SJ; Watson JV; Osborne RJ; Bleehen NM
Br J Cancer; 1994 Nov; 70(5):914-21. PubMed ID: 7947097
[TBL] [Abstract][Full Text] [Related]
73. In vivo etoposide-resistant C6 glioma cell line: significance of altered DNA topoisomerase II activity in multi-drug resistance.
Taki T; Ohnishi T; Arita N; Hiraga S; Hayakawa T
J Neurooncol; 1998 Jan; 36(1):41-53. PubMed ID: 9525824
[TBL] [Abstract][Full Text] [Related]
74. Genomic structure and chromosomal mapping of the gene coding for ICBP90, a protein involved in the regulation of the topoisomerase IIalpha gene expression.
Hopfner R; Mousli M; Garnier JM; Redon R; du Manoir S; Chatton B; Ghyselinck N; Oudet P; Bronner C
Gene; 2001 Mar; 266(1-2):15-23. PubMed ID: 11290415
[TBL] [Abstract][Full Text] [Related]
75. Functional compatibility between isoform alpha and beta of type II DNA topoisomerase.
Sakaguchi A; Kikuchi A
J Cell Sci; 2004 Mar; 117(Pt 7):1047-54. PubMed ID: 14996935
[TBL] [Abstract][Full Text] [Related]
76. BRCA1-mediated ubiquitination inhibits topoisomerase II alpha activity in response to oxidative stress.
Shinagawa H; Miki Y; Yoshida K
Antioxid Redox Signal; 2008 May; 10(5):939-49. PubMed ID: 18162055
[TBL] [Abstract][Full Text] [Related]
77. The α isoform of topoisomerase II is required for hypercompaction of mitotic chromosomes in human cells.
Farr CJ; Antoniou-Kourounioti M; Mimmack ML; Volkov A; Porter AC
Nucleic Acids Res; 2014 Apr; 42(7):4414-26. PubMed ID: 24476913
[TBL] [Abstract][Full Text] [Related]
78. RNA helicase A interacts with dsDNA and topoisomerase IIalpha.
Zhou K; Choe KT; Zaidi Z; Wang Q; Mathews MB; Lee CG
Nucleic Acids Res; 2003 May; 31(9):2253-60. PubMed ID: 12711669
[TBL] [Abstract][Full Text] [Related]
79. [Efficacy of hepatic arterial infusion of adriamycin and mitomycin C mixed with degradable starch microspheres for liver metastasis of colorectal cancer--correlation with the mRNA expression of DNA topoisomerase-IIalpha and glutathione-S transferase-pi in primary lesions].
Ishida H; Shirakawa K; Takeuchi I; Nakada H; Ohsawa T; Hayashi Y; Okada N; Yokoyama M; Inokuma S; Hashimoto D; Osada H; Matsumoto Y; Miura T
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1803-5. PubMed ID: 15553721
[TBL] [Abstract][Full Text] [Related]
80. β-Elemene Inhibits Cell Proliferation by Regulating the Expression and Activity of Topoisomerases I and IIα in Human Hepatocarcinoma HepG-2 Cells.
Gong M; Liu Y; Zhang J; Gao YJ; Zhai PP; Su X; Li X; Li Y; Hou L; Cui XN
Biomed Res Int; 2015; 2015():153987. PubMed ID: 26221582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
